Chimerix (CMRX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CMRX is expected to report earnings to rise 6.09% to -24 cents per share on October 31

Q3'24

Est.

$-0.24

Q2'24

Est.

$-0.23

Q1'24

Missed

by $0.04

Q4'23

Beat

by $0.04

Q3'23

Missed

by $0.04

The last earnings report on August 13 showed earnings per share of -23 cents, meeting the estimate of -23 cents. With 181.51K shares outstanding, the current market capitalization sits at 79.99M.

View a ticker or compare two or three

Compare

CMRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CMRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel oral antiviral therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2505 Meridian Parkway

Phone

+1 919 806-1074

Employees

Web

https://www.chimerix.com